Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans

Neurosurgical Focus

Volumn 36, Issue 1, 2014, Pages

  Khanna, Arjun ^a   Walcott, Brian P ^a   Kahle, Kristopher T ^a   Simard, J Marc ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxic; Edema; Glibenclamide; Glyburide; Metalloproteinase; Stroke; SUR1; TRPM4

Indexed keywords

ABCC8 PROTEIN, HUMAN; GLIBENCLAMIDE; SULFONYLUREA RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM4 PROTEIN, HUMAN;

BRAIN DISEASE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; GENETICS; HUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHYSIOLOGY; REVIEW;

BRAIN DISEASES; BRAIN EDEMA; BRAIN ISCHEMIA; CLINICAL TRIALS, PHASE II AS TOPIC; GLYBURIDE; HUMANS; INTRACRANIAL HEMORRHAGES; STROKE; SULFONYLUREA RECEPTORS; TRPM CATION CHANNELS;

EID: 84891891614     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.10.FOCUS13404     Document Type: Article

References (29)

1. Berrouschot J, Sterker M, Bettin S, Köster J, Schneider D: Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med 24:620-623, 1998
2. Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, et al: Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol 68:1245-1251, 2011
3. Chen M, Simard JM: Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain. J Neurosci 21:6512-6521, 2001
4. Edlow BL, Wu O, Singhal AB, Chaudhry ZA, Yoo AJ, Stern BJ, et al: Glyburide reduces cytotoxic edema within the cerebral peduncles in acute ischemic stroke. Stroke 44:ATP290, 2013 (Abstract)
5. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH: Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842:92-100, 1999
6. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al: Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. Stroke 30:1326-1332, 1999
7. Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, et al: Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 32:2117-2123, 2001
8. Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, et al: Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol 72:799-806, 2012
9. Kunte H, Schmidt S, Eliasziw M, del Zoppo GJ, Simard JM, Masuhr F, et al: Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke 38:2526-2530, 2007
10. Larrue V, von Kummer R, del Zoppo G, Bluhmki E: Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28:957-960, 1997
11. Lindley RI, Wardlaw JM, Sandercock PAG, Rimdusid P, Lewis SC, Signorini DF, et al: Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction. J Stroke Cerebrovasc Dis 13:235-246, 2004
12. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, et al: Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39:2249-2256, 2008
13. Pham L, O'Connor S, Yarbrough K, Jacobson S, Stern BJ, Sheth KN, et al: Intravenous glyburide treatment is associated with reduced matrix metalloproteinase-9 in human acute stroke. Stroke 44:ATMP22, 2013 (Abstract)
14. Rajasekaran SA, Beyenbach KW, Rajasekaran AK: Interactions of tight junctions with membrane channels and transporters. Biochim Biophys Acta 1778:757-769, 2008
15. Sheth KN: Pilot GAMES (Glyburide Advantage in Malignant Edema and Stroke). Neurotherapeutics 10:545, 2013 (Abstract)
16. Sheth KN, Kimberly WT, Elm JJ, Kent TA, Mandava P, Yoo AJ, et al: Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke [epub ahead of print], 2013
17. Silver FL, Fang J, Robertson AC, Casaubon L, Kapral MK: Possible neuroprotective effects of sufonylureas in diabetic patients with acute ischemic stroke. Stroke 40:e156, 2009 (Abstract)
18. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, et al: Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med 12:433-440, 2006
19. Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, et al: Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Ann N Y Acad Sci 1268:95-107, 2012
20. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V: Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 6:258-268, 2007
21. Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V: Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 41:531-537, 2010
22. Simard JM, Woo SK, Tsymbalyuk N, Voloshyn O, Yurovsky V, Ivanova S, et al: Glibenclamide-10-h Treatment Window in a Clinically Relevant Model of Stroke. Transl Stroke Res 3:286-295, 2012
23. Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V: Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 40:604-609, 2009
24. Sumii T, Lo EH: Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33:831-836, 2002
25. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, et al: Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36:1954-1959, 2005
26. Walcott BP, Kahle KT, Simard JM: Novel treatment targets for cerebral edema. Neurotherapeutics 9:65-72, 2012
27. Walcott BP, Miller JC, Kwon CS, Sheth SA, Hiller M, Cronin CA, et al: Outcomes in severe middle cerebral artery ischemic stroke. Neurocrit Care [epub ahead of print], 2013
28. Wali B, Ishrat T, Atif F, Hua F, Stein DG, Sayeed I: Glibenclamide administration attenuates infarct volume, hemispheric swelling, and functional impairments following permanent focal cerebral ischemia in rats. Stroke Res Treat 2012: 460909, 2012
29. Woo SK, Kwon MS, Ivanov A, Gerzanich V, Simard JM: The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem 288:3655-3667, 2013